Eloxx Pharmaceuticals, Inc.
ELOX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,592 | -$4,341 | -$6,230 | -$6,319 |
| Dep. & Amort. | $188 | $185 | $186 | $178 |
| Deferred Tax | -$495 | $4 | $0 | -$35 |
| Stock-Based Comp. | $418 | $610 | $597 | $641 |
| Change in WC | -$250 | $1,429 | -$1,906 | -$270 |
| Other Non-Cash | $281 | $47 | $539 | $144 |
| Operating Cash Flow | -$3,450 | -$2,066 | -$6,814 | -$5,661 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $233 | $0 | $11 | $0 |
| Investing Cash Flow | $233 | $14 | $11 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$220 | $0 | -$7,500 | $0 |
| Stock Issued | $3,459 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $431 | $1,428 | $0 | $312 |
| Financing Cash Flow | $3,670 | $1,428 | -$7,500 | $312 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $453 | -$624 | -$14,303 | -$5,349 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,541 | $5,165 | $19,468 | $24,817 |
| End Cash | $4,994 | $4,541 | $5,165 | $19,468 |
| Free Cash Flow | -$3,450 | -$2,066 | -$6,814 | -$5,661 |